NRAS and neoplasm: The outstanding importance of the RAS/RAF signaling pathway is documented by the observation that BRAF and NRAS mutations—exclusively NRAS or BRAF is mutated in a tumor—together are found in over 80% of melanomas and by inhibitors of mutated BRAF that are clearly effective in melanoma therapy.